Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression

被引:78
作者
Hatano, H
Vogel, S
Yoder, C
Metcalf, JA
Dewar, R
Davey, RT
Polis, MA
机构
[1] NIAID, Immunoregulat Lab, Bethesda, MD 20892 USA
[2] NIH, Dept Crit Care Med, Warren Magnuson Clin Ctr, Bethesda, MD 20892 USA
[3] Sci Applicat Int Corp, Frederick, MD USA
关键词
HIV; highly active antiretroviral therapy; viral load; viral load setpoint;
D O I
10.1097/00002030-200007070-00008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To evaluate the relationship between the HIV viral burden in individuals prior to receiving highly-active antiretroviral therapy (HAART) and the viral burden after withdrawal of HAART. Design and setting: Retrospective cohort study at the National Institutes of Health, Bethesda, Maryland, USA. Patients: Fourteen HIV-infected patients who achieved and maintained viral control on HAART who subsequently discontinued HAART. Main outcome measures: Pre- and post-HAART viral loads measured from plasma or serum. Results: Patients achieved viral control (< 500 copies/ml) on HAART in a median 28 days (range, 15-490 days; mean, 72 days), maintained viral control for a median 661 days (range, 53-1067 days; mean, 611 days), and subsequently discontinued HAART for a median 49 days (range, 14-196 days; mean, 73 days). The median difference between the pre- and post-HAART viral loads was 0.16 log(10) (range, -0.72 to 1.05 log(10); mean, 0.19 log(10)). The median absolute difference between the pre- and post HAART viral loads was 0.43 log(10) (range, 0.06-1.05 log(10); mean, 0.46 log(10)). Nine individuals had post-HAART values higher than pre-HAART values, five had lower values. Median duration between pre- and post-HAART viral load measurements was 1757 days (range, 117-3177 days; mean, 1756 days), or 4.8 years. Conclusions: After discontinuing HAART, individuals had rebounds in their viral burdens approximating pre-HAART levels, even after a significant lapse of time approaching 5 years. Our data suggest that an intrinsic viral load set-point may exist, and that a single interruption of an effective regimen with viral suppression for almost 2 years does not significantly alter this set-point. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:1357 / 1363
页数:7
相关论文
共 33 条
[1]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[2]   The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements [J].
Brambilla, D ;
Reichelderfer, PS ;
Bremer, JW ;
Shapiro, DE ;
Hershow, RC ;
Katzenstein, DA ;
Hammer, SM ;
Jackson, B ;
Collier, AC ;
Sperling, RS ;
Fowler, MG ;
Coombs, RW .
AIDS, 1999, 13 (16) :2269-2279
[3]   An audit of place of death of cancer patients in a semi-rural Scottish practice [J].
Carroll, DS .
PALLIATIVE MEDICINE, 1998, 12 (01) :51-53
[4]   Declining HIV/AIDS mortality in New York City [J].
Chiasson, MA ;
Berenson, L ;
Li, WH ;
Schwartz, S ;
Singh, T ;
Forlenza, S ;
Mojica, BA ;
Hamburg, MA .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (01) :59-64
[5]   AIDS - Re-emergence of HIV after stopping therapy [J].
Chun, TW ;
Davey, RT ;
Engel, D ;
Lane, HC ;
Fauci, AS .
NATURE, 1999, 401 (6756) :874-875
[6]   Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].
Chun, TW ;
Stuyver, L ;
Mizell, SB ;
Ehler, LA ;
Mican, JAM ;
Baseler, M ;
Lloyd, AL ;
Nowak, MA ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197
[7]   HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression [J].
Davey, RT ;
Bhat, N ;
Yoder, C ;
Chun, TW ;
Metcalf, JA ;
Dewar, R ;
Natarajan, V ;
Lempicki, RA ;
Adelsberger, JW ;
Millers, KD ;
Kovacs, JA ;
Polis, MA ;
Walker, RE ;
Falloon, L ;
Masur, H ;
Gee, D ;
Baseler, M ;
Dimitrov, DS ;
Fauci, AS ;
Lane, HC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) :15109-15114
[8]  
Davey RT, 1997, J INFECT DIS, V175, P781, DOI 10.1086/513971
[9]   Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment [J].
deJong, MD ;
deBoer, RJ ;
deWolf, F ;
Foudraine, NA ;
Boucher, CAB ;
Goudsmit, J ;
Lange, JMA .
AIDS, 1997, 11 (11) :F79-F84
[10]   Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy [J].
Dornadula, G ;
Zhang, H ;
VanUitert, B ;
Stern, J ;
Livornese, L ;
Ingerman, MJ ;
Witek, J ;
Kedanis, RJ ;
Natkin, J ;
DeSimone, J ;
Pomerantz, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (17) :1627-1632